Business Strategy Our goal is to become a leading interventional cardiology device company with an initial focus on Asia and Europe. We plan to accomplish our goal through the following strategies:

Develop vertically-integrated capabilities

• We have internally developed the technology to address each component of a drug-eluting stent system, including stents, stent delivery catheters, a polymer and a proprietary drug.
  
  
• We believe our vertically-integrated capabilities provide a competitive advantage for pursuing product improvements independent of third-party sources and help to maintain higher overall product quality.

Continue to explore strategic relationships

• We entered into licensing agreements with Terumo and Guidant to leverage their existing market positions in interventional cardiology.
  
  
• We entered into relationships with certain specialty stent companies with complementary medical technologies to provide us with access to their products and opportunities to expand the application of our proprietary technologies.

Maintain strong relationships with industry leaders

• We are in the process of formally establishing a scientific advisory board comprised of leading interventional cardiologists and physicians.
  
  
• These relationships are expected to provide us with a significant understanding of changing market and clinical dynamics to allow us to respond rapidly to the changing needs of patients and physicians.

Maintain technical leadership and strengthen intellectual property portfolio

• We consistently strive to develop and introduce innovative proprietary products.
  
  
• Our most recent efforts focused on low-profile, flexible stents and specialty catheters that operate in difficult-to-treat and smaller blood vessels.
  
  
• We have patents issued and applications pending covering innovations associated with our critical care and interventional cardiology products.

Acquire or license complementary technologies

• We plan to acquire or license complementary technologies and products to broaden product line, expand addressable markets and provide new solutions for unmet medical needs.